1. Home
  2. HWC vs PTCT Comparison

HWC vs PTCT Comparison

Compare HWC & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hancock Whitney Corporation

HWC

Hancock Whitney Corporation

HOLD

Current Price

$65.88

Market Cap

5.2B

Sector

Finance

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$78.16

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWC
PTCT
Founded
1883
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.3B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
HWC
PTCT
Price
$65.88
$78.16
Analyst Decision
Strong Buy
Buy
Analyst Count
7
17
Target Price
$70.71
$73.76
AVG Volume (30 Days)
762.6K
2.3M
Earning Date
01-20-2026
11-04-2025
Dividend Yield
2.73%
N/A
EPS Growth
24.84
N/A
EPS
5.57
8.94
Revenue
$1,435,973,000.00
$1,779,150,000.00
Revenue This Year
$10.91
$128.32
Revenue Next Year
$5.07
N/A
P/E Ratio
$11.83
$8.34
Revenue Growth
8.27
97.54
52 Week Low
$43.90
$35.95
52 Week High
$67.10
$87.50

Technical Indicators

Market Signals
Indicator
HWC
PTCT
Relative Strength Index (RSI) 65.78 56.02
Support Level $65.28 $73.78
Resistance Level $67.10 $76.17
Average True Range (ATR) 1.42 2.72
MACD 0.13 -0.52
Stochastic Oscillator 73.13 61.50

Price Performance

Historical Comparison
HWC
PTCT

About HWC Hancock Whitney Corporation

Hancock Whitney Corp operates bank offices and financial centers. The company offers a range of traditional and online banking services to commercial, small business, and retail customers, providing a variety of transaction and savings deposit products, treasury management services, secured and unsecured loan products (including revolving credit facilities), letters of credit, and similar financial guarantees. The Bank provides trust and investment management services to retirement plans, corporations, and individuals and provides its customers access to investment advisory and brokerage products.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Share on Social Networks: